Month: April 2019

Eyenuk’s AI Eye Screening System For Diabetic Retinopathy Demonstrates Exceptional Performance In A Prospective, Multi-Center, Pivotal Clinical Trial

Investigators Report the EyeArt System Achieved 95.5% Sensitivity, 86.5% Specificity and 97% Imageability, while Meeting All Primary Endpoints with p

Hospitals in Taiwan Make a Commitment to Eliminate Preventable Patient Harm & Death in Hospitals

IRVINE, Calif. & TAICHUNG,Taiwan--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/0x2020?src=hash" target="_blank"gt;#0x2020lt;/agt;--The Patient Safety Movement Foundation (PSMF) and the Taiwan Patient Safety Culture Club (TPSCC) announced today...

Santen and Glaukos Enter into Collaboration and Distribution Agreement for Exclusive Distribution of the MicroShunt (DE-128) in the United States

OSAKA, Japan & SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Santen Pharmaceutical Co., Ltd. (“Santen” TSE: 4536) and Glaukos Corporation (“Glaukos” NYSE: GKOS), announced...

error: Content is protected !!